Los Angeles Capital Management
MBIO icon

Los Angeles Capital Management’s Mustang Bio MBIO Stock Holding History

Los Angeles Capital Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-183
Closed -$227K – 1456
2021
Q4 		$227K Buy
183
+37
+25% +$59.7K ﹤0.01% 1317
2021
Q3 		$295K Buy
146
+7
+5% +$15K ﹤0.01% 1315
2021
Q2 		$346K Sell
139
-1
-0.7% -$2.45K ﹤0.01% 1339
2021
Q1 		$348K Buy
140
+17
+14% +$50.5K ﹤0.01% 1378
2020
Q4 		$350K Sell
123
-6
-5% -$14.3K ﹤0.01% 1329
2020
Q3 		$304K Buy
129
+5
+4% +$12.3K ﹤0.01% 1264
2020
Q2 		$296K Buy
124
+54
+77% +$126K ﹤0.01% 1290
2020
Q1 		$141K Buy
+70
New +$179K ﹤0.01% 1250

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Los Angeles Capital Management's MBIO Position: Q1 2022 in Review

Los Angeles Capital Management sold out of Mustang Bio (MBIO) in Q1 2022, closing a stake of 183 shares — an estimated $227K sold.

Los Angeles Capital Management first reported a position in MBIO in Q1 2020 and held it in 8 quarters. The position peaked at $350K in Q4 2020. 81 funds tracked by Wall St. Rank hold MBIO as of Q1 2022.

  • Los Angeles Capital Management reported no remaining Mustang Bio position as of Q1 2022 after selling out during the quarter.
  • Los Angeles Capital Management sold 183 Mustang Bio shares in Q1 2022, an estimated $227K.
  • Los Angeles Capital Management first reported a position in Mustang Bio in Q1 2020 and held it in 8 quarters.
  • Los Angeles Capital Management's Mustang Bio position peaked at $350K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2022.

Based on Los Angeles Capital Management's 13F filing for Q1 2022, filed 6 May 2022.